AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment - Top-Institutions - MDSpire

AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment

  • By

  • David Reinecke

  • Nina Müller

  • Anna-Katharina Meissner

  • Gina Fürtjes

  • Lili Leyer

  • Claire Wang

  • Adrian Ion-Margineanu

  • Nader Maarouf

  • Andrew Smith

  • Todd C. Hollon

  • Cheng Jiang

  • Xinhai Hou

  • Abdulkader Al-Shughri

  • Lisa I. Körner

  • Georg Widhalm

  • Thomas Roetzer-Pejrimovsky

  • Matija Snuderl

  • Sandra Camelo-Piragua

  • John G. Golfinos

  • Roland Goldbrunner

  • Daniel A. Orringer

  • Niklas von Spreckelsen

  • Volker Neuschmelting

  • March 17, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Pathology
    • Biomedical Engineering
    • Artificial Intelligence

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Pathology
    • Biomedical Engineering

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Pathology
    • Biomedical Imaging
    • Artificial Intelligence

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurosurgery
    • Pathology
    • Biomedical Engineering

Original Source(s)

AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment

  • by David Reinecke, Nina Müller, Anna-Katharina Meissner, Gina Fürtjes, Lili Leyer, Claire Wang, Adrian Ion-Margineanu, Nader Maarouf, Andrew Smith, Todd C. Hollon, Cheng Jiang, Xinhai Hou, Abdulkader Al-Shughri, Lisa I. Körner, Georg Widhalm, Thomas Roetzer-Pejrimovsky, Matija Snuderl, Sandra Camelo-Piragua, John G. Golfinos, Roland Goldbrunner, Daniel A. Orringer, Niklas von Spreckelsen, Volker Neuschmelting

  • March 17, 2026

Related Content

PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer

The Importance of Molecular Profiling in Delivering Guideline-Recommended Care—From Genetic Sequencing to Patient Outcomes

Manufacturing Inside the Patient

How 2025 marked biology’s shift toward engineering discipline